Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Diffusion Pharmaceuticals Inc (DFFN)

1.02   -0.04 (-3.77%) 03-03 16:19
Open: 1.04 Pre. Close: 1.06
High: 1.065 Low: 1
Volume: 5,955,761 Market Cap: 104M
Diffusion Pharmaceuticals, Inc. is a clinical stage company, which engages in the development of treatment for life threatening conditions. The company is headquartered in Charlottesville, Virginia and currently employs 10 full-time employees. The firm is focused on developing standard-of-care treatments, including radiation therapy and chemotherapy. The firm's lead product candidate, transcrocetinate sodium, also known as trans sodium crocetinate (TSC) is used in various cancer types, in which tumor oxygen deprivation (hypoxia) is known to diminish the effectiveness of treatments. The firm's Diffusion's technology is targeted at overcoming treatment-resistance in solid cancerous tumors by combining its lead product candidate, TSC, with standard-of-care radiation and chemotherapy regimens, thus effecting a better patient survival outcome without the addition of harmful side effects. Its clinical development plan targets TSC at the radiation and chemotherapy sensitization of hypoxic tumor types, with an initial focus on primary brain cancer (glioblastoma or GBM), pancreatic cancer, and brain metastases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.101 - 1.108 1.108 - 1.113
Low: 1.034 - 1.042 1.042 - 1.048
Close: 1.049 - 1.061 1.061 - 1.07

Technical analysis

as of: 2021-03-03 4:02:37 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 1.76     One year: 2.16
Support: Support1: 0.96    Support2: 0.80
Resistance: Resistance1: 1.51    Resistance2: 1.85
Pivot: 1.25
Moving Average: MA(5): 1.07     MA(20): 1.27
MA(100): 0.95     MA(250): 0.88
MACD: MACD(12,26): -0.02     Signal(9): 0.03
Stochastic oscillator: %K(14,3): 11.61     %D(3): 14.48
RSI: RSI(14): 42.81
52-week: High: 1.85  Low: 0.25  Change(%): 155.0
Average Vol(K): 3-Month: 755229  10-Days: 915097

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
DFFN has closed above bottom band by 18.6%. Bollinger Bands are 137.1% wider than normal. The large width of the bands suggest high volatility as compared to DFFN's normal range. The bands have been in this wide range for 16 bars. This is a sign that the current trend might continue.

Headline News

Fri, 26 Feb 2021
Diffusion Pharmaceuticals Inc. - Consensus Indicates Potential 137.1% Upside - DirectorsTalk Interviews

Tue, 23 Feb 2021
Will Diffusion Pharmaceuticals Inc (DFFN) Beat the Rest of the Stocks in the Healthcare Sector? - InvestorsObserver

Fri, 19 Feb 2021
Is Diffusion Pharmaceuticals Inc (DFFN) a Good Choice in Biotechnology Friday? - InvestorsObserver

Thu, 18 Feb 2021
Is Diffusion Pharmaceuticals Inc (DFFN) Stock a Great Value? - InvestorsObserver

Thu, 18 Feb 2021
Diffusion Pharmaceuticals Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares of Common Stock - Yahoo Finance

Wed, 17 Feb 2021
Diffusion Pharmaceuticals Announces Closing of $30 Million Bought Deal Offering of Common Stock - GlobeNewswire

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 64
Shares Float (M) 64
% Held by Insiders 0.21
% Held by Institutions 10.71
Shares Short (K) 722
Shares Short P. Month (K) 897

Stock Financials

EPS -0.383
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.450
Profit Margin
Operating Margin
Return on Assets (ttm) -38.6
Return on Equity (ttm) -65.7
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.230
Qtrly Earnings Growth
Operating Cash Flow (M) -13
Levered Free Cash Flow (M) -7

Stock Valuations

PE Ratio -2.66
PEG Ratio
Price to Book value 2.27
Price to Sales
Price to Cash Flow -5.18

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.